within Pharmacolibrary.Drugs.ATC.M;

model M01AE09
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 1.3166666666666666e-06,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0103,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.02,
    Tlag           = 10.200000000000001,            
    Vdp             = 0.0088,
    k12             = 4.9,
    k21             = 4.9
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>M01AE09</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Flurbiprofen is a nonsteroidal anti-inflammatory drug (NSAID) primarily used for the treatment of inflammation and pain associated with conditions such as rheumatoid arthritis and osteoarthritis. It has analgesic, anti-inflammatory, and antipyretic properties. The drug is approved and used in clinical practice for acute and chronic pain management, as well as in the treatment of inflammatory disorders.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult subjects following oral administration.</p><h4>References</h4><ol><li><p>Kaiser, DG, et al., &amp; Lomen, PL (1986). Pharmacokinetics of flurbiprofen. <i>The American journal of medicine</i> 80(3A) 10–15. DOI:<a href=&quot;https://doi.org/10.1016/0002-9343(86)90104-x&quot;>10.1016/0002-9343(86)90104-x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3963013/&quot;>https://pubmed.ncbi.nlm.nih.gov/3963013</a></p></li><li><p>Davies, NM (1995). Clinical pharmacokinetics of flurbiprofen and its enantiomers. <i>Clinical pharmacokinetics</i> 28(2) 100–114. DOI:<a href=&quot;https://doi.org/10.2165/00003088-199528020-00002&quot;>10.2165/00003088-199528020-00002</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7736686/&quot;>https://pubmed.ncbi.nlm.nih.gov/7736686</a></p></li><li><p>Suri, A, et al., &amp; Derendorf, H (1997). Pharmacokinetics and pharmacodynamics of enantiomers of ibuprofen and flurbiprofen after oral administration. <i>International journal of clinical pharmacology and therapeutics</i> 35(1) 1–8. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9021434/&quot;>https://pubmed.ncbi.nlm.nih.gov/9021434</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end M01AE09;
